Hypoxia stimulates 18F-Fluorodeoxyglucose uptake in breast cancer cells via Hypoxia inducible Factor-1 and AMP-activated protein kinase
Authors:
- Matteo ZandaMZMatteo Zanda
- Ian N. FlemingIFIan N. Fleming
- 1 August 2013
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 40 (6) , 858-864
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg EffectPLOS ONE, 2011
- The altered metabolism of tumors: HIF-1 and its role in the Warburg effectAdvances in Enzyme Regulation, 2010
- Molecular imaging of hypoxia with radiolabelled agentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- FDG uptake, a surrogate of tumour hypoxia?European Journal of Nuclear Medicine and Molecular Imaging, 2008
- Clinical biomarkers for hypoxia targetingCancer and Metastasis Reviews, 2008
- Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cellsNuclear Medicine and Biology, 2006
- Suppression of hypoxia inducible factor-1α (HIF-1α) by YC-1 is dependent on murine double minute 2 (Mdm2)Biochemical and Biophysical Research Communications, 2006
- Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumorsNuclear Medicine and Biology, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Influence of hypoxia on tracer accumulation in squamous-cell carcinoma: in vitro evaluation for PET imagingNuclear Medicine and Biology, 1996